Chromosomal Microarray Analysis (CMA) or Copy Number Analysis for the Genetic Evaluation of Patients with Developmental Delay, Intellectual Disability, Autism Spectrum Disorder, or Congenital Anomalies

Regence BCBS · PayerPolicy · REGENCE-GT58

Summary of the payer’s published policy. Not a coverage determination — confirm with Regence BCBS before submitting.

Free account. Policy pages stay open to everyone.

Codes in this policy

Each code’s status is what the policy records for it. This page does not show the policy’s criteria. Read them in the payer’s source.